Prosecution Insights
Last updated: November 20, 2026

Melissa Jean Perreira, USPTO Patent Examiner

Listed by the USPTO as PERREIRA, MELISSA JEAN

Tech Center 1600 • Art Units: 1618

This examiner grants 52% of resolved cases

Analysis

PERREIRA, MELISSA JEAN is assigned to Tech Center 1600 and art unit 1618. The profile records 837 resolved cases and an allowance rate of 52.1%. The interview lift is 25.7%, showing a positive recorded association between interviews and allowance outcomes. The median time to allowance is 1375 days.

The listed companies are The Johns Hopkins University, Rakuten Medical Inc., and Hoffmann-La Roche Inc. The leading firms are MORRISON & FOERSTER LLP, MORSE, BARNES-BROWN & PENDLETON, P.C., and FOLEY & LARDNER LLP. Practitioners may combine early interview preparation with focused amendments and continuation planning in view of the recorded pendency.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Performance Statistics

52.1%
Allow Rate
-7.9% vs TC avg
885
Total Applications
+25.7%
Interview Lift
1375
Avg Prosecution Days
Based on 837 resolved cases, 2023–2026

Rejection Statute Breakdown

2.1%
§101 Eligibility
12.7%
§102 Novelty
56.0%
§103 Obviousness
16.6%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
17542358 PAPD5 AND PAPD7 INHIBITORS FOR TREATING A HEPATITIS B INFECTION Non-Final OA HOFFMANN-LA ROCHE INC.
18062577 HEMOSTATIC MATERIAL COMPOSITION Non-Final OA FUJIFILM CORPORATION
19240908 METHOD OF TREATING PROSTATE CANCER Non-Final OA Novartis AG
16400922 Pharmaceutical Compositions of Near IR Closed Chain, Sulfo-Cyanine Dyes Final Rejection Intuitive Surgical Operations, Inc.
17961299 RADIOLABELED COMPOUNDS TARGETING THE PROSTATE-SPECIFIC MEMBRANE ANTIGEN Non-Final OA THE UNIVERSITY OF BRITISH COLUMBIA
18990863 IMAGING AND RADIOTHERAPEUTICS AGENTS TARGETING FIBROBLAST-ACTIVATION PROTEIN-ALPHA (FAP-ALPHA) Final Rejection The Johns Hopkins University
18052804 PSMA-TARGETING COMPOUNDS AND USES THEREOF Non-Final OA The Johns Hopkins University
18321684 ACTIVITY-BASED PROBE COMPOUNDS, COMPOSITIONS, AND METHODS OF USE Non-Final OA THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
17479395 FORMULATION OF ACOUSTICALLY ACTIVATABLE PARTICLES HAVING LOW VAPORIZATION ENERGY AND METHODS FOR USING SAME Non-Final OA The Regents of the University of Colorado, a body corporate

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Who Appears Before This Examiner

Top companies before this examiner

Law firms appearing most often

Frequently Asked Questions

What is examiner Melissa Jean Perreira's allowance rate?

52.1% of resolved applications examined by Melissa Jean Perreira were allowed (837 resolved cases), compared with 33.2% across Art Unit 1618 over the last five years.

Does an interview help with examiner Melissa Jean Perreira?

This examiner's interview lift is +25.7 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.

How long does examiner Melissa Jean Perreira take to allow a patent?

Applications allowed by Melissa Jean Perreira took 1,375 days on average from filing to allowance.

Which art unit does examiner Melissa Jean Perreira work in?

Melissa Jean Perreira examines applications in Art Unit 1618 in Tech Center 1600 (Biotechnology & Pharmaceuticals).

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month